Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.
about
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterationsThe challenges of Chagas Disease-- grim outlook or glimmer of hope.Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease.Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease
P2860
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@en
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@nl
type
label
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@en
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@nl
prefLabel
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@en
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@nl
P2093
P2860
P1476
Enzyme-linked immunoassay usin ...... disease after drug treatment.
@en
P2093
Abilio Augusto Fragata-Filho
Antonio Marcos de Apparecida Levy
Mauricio M Rodrigues
Vera Lucia Pereira-Chioccola
P2860
P304
P356
10.1128/CDLI.10.5.826-830.2003
P577
2003-09-01T00:00:00Z